Literature DB >> 31548419

Predicting kidney transplant outcomes with partial knowledge of HLA mismatch.

Charles F Manski1,2, Anat R Tambur3, Michael Gmeiner4.   

Abstract

We consider prediction of graft survival when a kidney from a deceased donor is transplanted into a recipient, with a focus on the variation of survival with degree of human leukocyte antigen (HLA) mismatch. Previous studies have used data from the Scientific Registry of Transplant Recipients (SRTR) to predict survival conditional on partial characterization of HLA mismatch. Whereas earlier studies assumed proportional hazards models, we used nonparametric regression methods. These do not make the unrealistic assumption that relative risks are invariant as a function of time since transplant, and hence should be more accurate. To refine the predictions possible with partial knowledge of HLA mismatch, it has been suggested that HaploStats statistics on the frequencies of haplotypes within specified ethnic/national populations be used to impute complete HLA types. We counsel against this, showing that it cannot improve predictions on average and sometimes yields suboptimal transplant decisions. We show that the HaploStats frequency statistics are nevertheless useful when combined appropriately with the SRTR data. Analysis of the ecological inference problem shows that informative bounds on graft survival probabilities conditional on refined HLA typing are achievable by combining SRTR and HaploStats data with immunological knowledge of the relative effects of mismatch at different HLA loci.

Entities:  

Keywords:  HLA matching; ecological inference; nonparametric prediction; transplant risk assessment

Year:  2019        PMID: 31548419      PMCID: PMC6789916          DOI: 10.1073/pnas.1911281116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

Review 1.  Matching donor and recipient based on predicted indirectly recognizable human leucocyte antigen epitopes.

Authors:  K Geneugelijk; E Spierings
Journal:  Int J Immunogenet       Date:  2018-02-21       Impact factor: 1.466

Review 2.  Current role of human leukocyte antigen matching in kidney transplantation.

Authors:  Caner Süsal; Gerhard Opelz
Journal:  Curr Opin Organ Transplant       Date:  2013-08       Impact factor: 2.640

3.  Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates.

Authors:  Akinlolu O Ojo; Julie A Hanson; Herwig-Ulf Meier-Kriesche; Chike N Okechukwu; Robert A Wolfe; Alan B Leichtman; Lawrence Y Agodoa; Bruce Kaplan; Friedrich K Port
Journal:  J Am Soc Nephrol       Date:  2001-03       Impact factor: 10.121

4.  A simple tool to predict outcomes after kidney transplant.

Authors:  Bertram L Kasiske; Ajay K Israni; Jon J Snyder; Melissa A Skeans; Yi Peng; Eric D Weinhandl
Journal:  Am J Kidney Dis       Date:  2010-11       Impact factor: 8.860

5.  Incidence and impact of de novo donor-specific alloantibody in primary renal allografts.

Authors:  Matthew J Everly; Lorita M Rebellato; Carl E Haisch; Miyuki Ozawa; Karen Parker; Kimberly P Briley; Paul G Catrou; Paul Bolin; William T Kendrick; Scott A Kendrick; Robert C Harland; Paul I Terasaki
Journal:  Transplantation       Date:  2013-02-15       Impact factor: 4.939

6.  Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept.

Authors:  I I Doxiadis; J M Smits; G M Schreuder; G G Persijn; H C van Houwelingen; J J van Rood; F H Claas
Journal:  Lancet       Date:  1996-09-28       Impact factor: 79.321

7.  A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index.

Authors:  Panduranga S Rao; Douglas E Schaubel; Mary K Guidinger; Kenneth A Andreoni; Robert A Wolfe; Robert M Merion; Friedrich K Port; Randall S Sung
Journal:  Transplantation       Date:  2009-07-27       Impact factor: 4.939

Review 8.  Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation.

Authors:  Chris Wiebe; Peter Nickerson
Journal:  Curr Opin Organ Transplant       Date:  2013-08       Impact factor: 2.640

9.  Summary of 2017 FDA Public Workshop: Antibody-mediated Rejection in Kidney Transplantation.

Authors:  Ergun Velidedeoglu; Marc W Cavaillé-Coll; Shukal Bala; Ozlem A Belen; Yan Wang; Renata Albrecht
Journal:  Transplantation       Date:  2018-06       Impact factor: 4.939

Review 10.  HLA-Epitope Matching or Eplet Risk Stratification: The Devil Is in the Details.

Authors:  Anat R Tambur
Journal:  Front Immunol       Date:  2018-08-31       Impact factor: 7.561

View more
  3 in total

1.  The Accuracy of Sequence-Specific Oligonucleotide and Real-Time Polymerase Chain Reaction HLA Typing in Determining the Presence of Pre-Transplant Donor-Specific Anti-HLA Antibodies and Total Eplet Mismatches for Deceased Donor Kidney Transplantation.

Authors:  Nicholas G Larkins; Lloyd D'Orsogna; Anne Taverniti; Ankit Sharma; Aron Chakera; Doris Chan; Anoushka Krishnan; Germaine Wong; Wai H Lim
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

2.  Low Hydrophobic Mismatch Scores Calculated for HLA-A/B/DR/DQ Loci Improve Kidney Allograft Survival.

Authors:  Dulat Bekbolsynov; Beata Mierzejewska; Jadwiga Borucka; Robert S Liwski; Anna L Greenshields; Joshua Breidenbach; Bradley Gehring; Shravan Leonard-Murali; Sadik A Khuder; Michael Rees; Robert C Green; Stanislaw M Stepkowski
Journal:  Front Immunol       Date:  2020-10-29       Impact factor: 7.561

Review 3.  The Impact of Donor and Recipient Genetic Variation on Outcomes After Solid Organ Transplantation: A Scoping Review and Future Perspectives.

Authors:  Yanni Li; Lianne M Nieuwenhuis; Brendan J Keating; Eleonora A M Festen; Vincent E de Meijer
Journal:  Transplantation       Date:  2021-12-28       Impact factor: 5.385

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.